Pyridostigmine Hydroxide is a quaternary ammonium compound acting as a reversible acetylcholinesterase inhibitor. As a key pharmaceutical agent, it is primarily prescribed for the treatment of myasthenia… Read more
Pyridostigmine Hydroxide is a quaternary ammonium compound acting as a reversible acetylcholinesterase inhibitor. As a key pharmaceutical agent, it is primarily prescribed for the treatment of myasthenia gravis, autonomic dysfunction leading to urinary retention, and for reversing the effects of non-depolarizing neuromuscular blocking agents when administered with atropine. Laboratories supporting the development and manufacturing of this medication utilize our high-quality reference standards, metabolites, and degradation products to ensure accurate analytical testing and rigorous quality control. These materials are essential for impurity profiling, allowing researchers to monitor the chemical stability and safety of the active pharmaceutical ingredient. Furthermore, stable isotope labelled compounds are available to serve as reliable internal standards for sophisticated mass spectrometry applications, facilitating precise quantification during method validation and stability studies in complex pharmaceutical matrices.